Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016YFC1301801 | Other Grant/Funding Number | National Key Technologies R&D Program of China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Complex brain arteriovenous malformations (bAVMs) in ≥3 Spetzler-Martin grades have long been challenges among cerebrovascular diseases. None of the traditional methods, such as microsurgical operation, endovascular intervention, or stereotactic radiotherapy, can completely eliminate complex bAVMs without a risk of neural function deterioration. The multistaged hybrid operation solved part of the challenge but remained risky in the installment procedures and intervals. The one-staged hybrid operation was applied in the surgical treatment of cerebrovascular diseases and proved to be a potentially safe and effective method for curing complex bAVMs. However, lacking the support of high-level evidence, its advantages remain unclear. This study was proposed to validate the benefits and risks of one-staged hybrid operation in the treatment of complex bAVMs, as well as its indications, key technologies, and workflows.
The study is being conducted from Jan 2016 to Dec 2020 with 20 cooperation units. It consists of 2 sets. The registry set is designed as a prospective real-world registry. The trial set is designed as a prospective pragmatic clinical trial, specifically for the patients with perforating arterial feeders. The two sets share a common grouping: the traditional operation group and the one-staged hybrid operation group. The assignment is based on the clinical condition in the registry set and is randomized in the trial set. End points will be evaluated at scheduled time points. The safety and efficiency of one-staged hybrid operation in treating complex bAVMs will be validated.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Traditional microsurgery group | Other | Patients receive only traditional microsurgical operations in traditional operating theaters or the one-staged hybrid operation theater. No endovascular intervention technique or intraoperative digital subtraction angiography(DSA) will be performed. The DSA will be performed in 3 days after the operation. |
|
| Hybrid operation group | Experimental | Patients receive microsurgical operation under the assistance of intraoperative DSA, endovascular embolization and/or balloon occlusion in the one-staged hybrid operating theater. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| one-staged hybrid operation | Procedure | An integrated procedure that consists of microsurgery, intraoperative DSA, endovascular intervention techniques and other assistance tools. All the procedures are performed in a one-staged operation without any intermission or any transfer of patients. |
| Measure | Description | Time Frame |
|---|---|---|
| neural function deterioration | Increasing of mRS and mRS>2 | 3 months after operation |
| Measure | Description | Time Frame |
|---|---|---|
| neural function deterioration in 6 months | Increasing of mRS and mRS>2 | 6 months after operation |
| neural function deterioration in 12 months | Increasing of mRS and mRS>2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shuo Wang, MD | Contact | 861059976510 | captain9858@vip.sina.com | |
| Jun Wu, MD | Contact | 861059976510 | wujunslf@126.com |
| Name | Affiliation | Role |
|---|---|---|
| Shuo Wang, MD | Beijing Tiantan Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Xuanwu Hospital, Capital Medical University | Recruiting | Beijing | Beijing Municipality | 100053 | China |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 31359304 | Derived | Wang M, Qiu H, Cao Y, Wang S, Zhao J. One-staged in situ embolization combined with surgical resection for eloquence protection of AVM: technical note. Neurosurg Rev. 2019 Sep;42(3):783-790. doi: 10.1007/s10143-019-01137-w. Epub 2019 Jul 30. | |
| 31039755 | Derived | Wang M, Jiao Y, Cao Y, Wang S, Zhao J. Surgical management of complex brain arteriovenous malformations with hybrid operating technique: study protocol of a prospective registry and a pragmatic clinical trial. BMC Neurol. 2019 Apr 30;19(1):75. doi: 10.1186/s12883-019-1289-3. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Traditional microsurgical operation | Procedure | The classical mode of operations in neurosurgery. The operation is performed with neurosurgical instruments and microscope. Some of assisting tools can be used in the operation, such as neuro-navigation, Doppler probe, neural electrophysiological monitoring and so on. But neither the intraoperative DSA nor endovascular intervention techniques is used in the operation |
|
| 12 months after operation |
| postoperative mortality | the fatality due to operation | 7 days after operation |
| operation-related complications | any complications that occur within 7 days from the date of operation, including intracranial hemorrhage or infarction, infection of the central nervous system, infection of the respiratory system, cranial nerve deficits, and other symptomatic complications | 7 days after operation |
| postoperative bAVMs residue | the bAVMs residue revealed by postoperative DSA or computed tomographic angiography | 7 days after operation |
| 3 months bAVMs residue | the bAVMs residue revealed by postoperative DSA or computed tomographic angiography | 3 months after operation |
| 6 months bAVMs residue | the bAVMs residue revealed by postoperative DSA or computed tomographic angiography | 6 months after operation |
| 12 months bAVMs residue | the bAVMs residue revealed by postoperative DSA or computed tomographic angiography | 12 months after operation |
| Beijing Tiantan Hospital Capital Medical University | Recruiting | Beijing | Beijing Municipality | 100070 | China |
|
| General Hospital of Rocket Army | Recruiting | Beijing | Beijing Municipality | 100088 | China |
|
| Qilu Hospital, Shandong University | Recruiting | Jinan | Shandong | 250012 | China |
|
| Qingdao Municipal Hospital | Recruiting | Qingdao | Shandong | 266034 | China |
|
| Huashan Hospital, Fudan University | Recruiting | Shanghai | Shanghai Municipality | 200040 | China |
|
| The Second Affiliated Hospital of Zhejiang University School of Medicine | Recruiting | Hangzhou | Zhejiang | 310009 | China |
|
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001165 | Arteriovenous Malformations |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D054079 | Vascular Malformations |
| D018376 | Cardiovascular Abnormalities |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Not provided
Not provided